Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Borris

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1993
Haemostatic activation in patients with head injury with and without simultaneous multiple traumaJ V Sørensen, H P Jensen, H B Rahr, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysisM R Lassen, L C Borris, H M Christiansen, et al.
Thrombosis Research|July 1, 1991
Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplastyL C Borris, J V Sørensen, M R Lassen, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1991
Biologic tolerance of two different low molecular weight heparinsH M Christiansen, M R Lassen, L C Borris, et al.
Haemostasis|March 1, 1993
Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunctionJ V Sørensen, H P Jensen, H B Rahr, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Biological tolerance of Logiparin, a low molecular weight heparin used in patients undergoing total hip replacementH M Christiansen, M Rud-Lassen, L C Borris, et al.
Acta Orthopaedica Scandinavica|February 1, 1991
Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placeboM R Lassen, L C Borris, H M Christiansen, et al.
The British Journal of Surgery|July 1, 1988
Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgeryM R Lassen, L C Borris, H M Christiansen, et al.
Archives of Orthopaedic and Trauma Surgery|January 1, 1989
Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamineM R Lassen, L C Borris, H M Christiansen, et al.
International Angiology : a Journal of the International Union of Angiology|February 16, 2008
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical useO E Dahl, L C Borris, D Bergqvist, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1993
Haemostatic activation in patients with head injury with and without simultaneous multiple traumaJ V Sørensen, H P Jensen, H B Rahr, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysisM R Lassen, L C Borris, H M Christiansen, et al.
Thrombosis Research|July 1, 1991
Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplastyL C Borris, J V Sørensen, M R Lassen, et al.
Seminars in Thrombosis and Hemostasis|October 1, 1991
Biologic tolerance of two different low molecular weight heparinsH M Christiansen, M R Lassen, L C Borris, et al.
Haemostasis|March 1, 1993
Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunctionJ V Sørensen, H P Jensen, H B Rahr, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Biological tolerance of Logiparin, a low molecular weight heparin used in patients undergoing total hip replacementH M Christiansen, M Rud-Lassen, L C Borris, et al.
Acta Orthopaedica Scandinavica|February 1, 1991
Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placeboM R Lassen, L C Borris, H M Christiansen, et al.
The British Journal of Surgery|July 1, 1988
Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgeryM R Lassen, L C Borris, H M Christiansen, et al.
Archives of Orthopaedic and Trauma Surgery|January 1, 1989
Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamineM R Lassen, L C Borris, H M Christiansen, et al.
International Angiology : a Journal of the International Union of Angiology|February 16, 2008
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical useO E Dahl, L C Borris, D Bergqvist, et al.
Pageof 5